These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Loss of function of TET2 cooperates with constitutively active KIT in murine and human models of mastocytosis. De Vita S; Schneider RK; Garcia M; Wood J; Gavillet M; Ebert BL; Gerbaulet A; Roers A; Levine RL; Mullally A; Williams DA PLoS One; 2014; 9(5):e96209. PubMed ID: 24788138 [TBL] [Abstract][Full Text] [Related]
26. Digital PCR: A Sensitive and Precise Method for Greiner G; Gurbisz M; Ratzinger F; Witzeneder N; Simonitsch-Klupp I; Mitterbauer-Hohendanner G; Mayerhofer M; Müllauer L; Sperr WR; Valent P; Hoermann G Clin Chem; 2018 Mar; 64(3):547-555. PubMed ID: 29237714 [TBL] [Abstract][Full Text] [Related]
27. Case Report: Evolution of Sciumè M; Ceparano G; Eller-Vainicher C; Fabris S; Lonati S; Croci GA; Baldini L; Grifoni FI Front Oncol; 2021; 11():734025. PubMed ID: 34917498 [TBL] [Abstract][Full Text] [Related]
29. High frequency of concomitant mastocytosis in patients with acute myeloid leukemia exhibiting the transforming KIT mutation D816V. Fritsche-Polanz R; Fritz M; Huber A; Sotlar K; Sperr WR; Mannhalter C; Födinger M; Valent P Mol Oncol; 2010 Aug; 4(4):335-46. PubMed ID: 20471335 [TBL] [Abstract][Full Text] [Related]
31. Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay. Kristensen T; Vestergaard H; Møller MB J Mol Diagn; 2011 Mar; 13(2):180-8. PubMed ID: 21354053 [TBL] [Abstract][Full Text] [Related]
32. Reduced DNA methylation and hydroxymethylation in patients with systemic mastocytosis. Leoni C; Montagner S; Deho' L; D'Antuono R; De Matteis G; Marzano AV; Merante S; Orlandi EM; Zanotti R; Monticelli S Eur J Haematol; 2015 Dec; 95(6):566-75. PubMed ID: 25688802 [TBL] [Abstract][Full Text] [Related]
33. Clinical Impact of Inherited and Acquired Genetic Variants in Mastocytosis. Nedoszytko B; Arock M; Lyons JJ; Bachelot G; Schwartz LB; Reiter A; Jawhar M; Schwaab J; Lange M; Greiner G; Hoermann G; Niedoszytko M; Metcalfe DD; Valent P Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33401724 [TBL] [Abstract][Full Text] [Related]
34. Comprehensive mutational profiling in advanced systemic mastocytosis. Schwaab J; Schnittger S; Sotlar K; Walz C; Fabarius A; Pfirrmann M; Kohlmann A; Grossmann V; Meggendorfer M; Horny HP; Valent P; Jawhar M; Teichmann M; Metzgeroth G; Erben P; Ernst T; Hochhaus A; Haferlach T; Hofmann WK; Cross NC; Reiter A Blood; 2013 Oct; 122(14):2460-6. PubMed ID: 23958953 [TBL] [Abstract][Full Text] [Related]
35. Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a [corrected] clonal hematological non-mast [corrected] cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F. Sotlar K; Bache A; Stellmacher F; Bültmann B; Valent P; Horny HP J Mol Diagn; 2008 Jan; 10(1):58-66. PubMed ID: 18165278 [TBL] [Abstract][Full Text] [Related]
36. Serum tryptase correlates with the KIT D816V mutation burden in adults with indolent systemic mastocytosis. Kristensen T; Broesby-Olsen S; Vestergaard H; Bindslev-Jensen C; Møller MB; Eur J Haematol; 2013 Aug; 91(2):106-11. PubMed ID: 23621866 [TBL] [Abstract][Full Text] [Related]
37. A new humanized in vivo model of KIT D816V+ advanced systemic mastocytosis monitored using a secreted luciferase. Bibi S; Zhang Y; Hugonin C; Mangean MD; He L; Wedeh G; Launay JM; Van Rijn S; Würdinger T; Louache F; Arock M Oncotarget; 2016 Dec; 7(50):82985-83000. PubMed ID: 27783996 [TBL] [Abstract][Full Text] [Related]
38. Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis. Jawhar M; Schwaab J; Schnittger S; Meggendorfer M; Pfirrmann M; Sotlar K; Horny HP; Metzgeroth G; Kluger S; Naumann N; Haferlach C; Haferlach T; Valent P; Hofmann WK; Fabarius A; Cross NC; Reiter A Leukemia; 2016 Jan; 30(1):136-43. PubMed ID: 26464169 [TBL] [Abstract][Full Text] [Related]
39. Systemic mastocytosis mimicking blastic plasmacytoid dendritic cell neoplasm: a case report. Zhang X; Han J; Zhu N; Ji Y; Hou Y Diagn Pathol; 2023 Feb; 18(1):17. PubMed ID: 36759849 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of optical genome mapping for detecting chromosomal translocation in clinical cytogenetics. Dai P; Zhu X; Pei Y; Chen P; Li J; Gao Z; Liang Y; Kong X Mol Genet Genomic Med; 2022 Jun; 10(6):e1936. PubMed ID: 35384386 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]